Literature DB >> 25435089

A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.

Sophie E M Veldhuijzen van Zanten1, Marc H A Jansen, Esther Sanchez Aliaga, Dannis G van Vuurden, W Peter Vandertop, Gertjan J L Kaspers.   

Abstract

INTRODUCTION: Children with diffuse intrinsic pontine glioma (DIPG) face a dismal prognosis, with a median overall survival of 9 months. Our aims are to determine the incidence of DIPG in the Netherlands and to identify points for improvement in clinical research, a prerequisite for increasing the chance to find a cure.
METHODS: We performed a population-based retrospective cohort study by evaluating all children diagnosed with DIPG in the Netherlands between 1990 and 2010.
RESULTS: The incidence of DIPG in the Netherlands corresponds with international literature. Between 1990 and 2010, a large heterogeneity of treatment schedules was applied and only a minority of patients was included in clinical trials. DISCUSSION: Given the rarity of DIPG, we emphasize the need for (inter-)national trials to facilitate the identification of potentially effective therapeutics in the future. This can be supported by the recent development of a European DIPG registry enabling international study collaborations.

Entities:  

Keywords:  brainstem tumor; chemotherapy; clinical trial; diffuse intrinsic pontine glioma; high-grade glioma; pediatric oncology; radiotherapy; treatment

Mesh:

Year:  2014        PMID: 25435089     DOI: 10.1586/14737140.2015.974563

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  19 in total

1.  Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC).

Authors:  Adriana Fonseca; Samina Afzal; Lynette Bowes; Bruce Crooks; Valerie Larouche; Nada Jabado; Sebastien Perreault; Donna L Johnston; Shayna Zelcer; Adam Fleming; Katrin Scheinemann; Mariana Silva; Magimairajan Issai Vanan; Chris Mpofu; Beverly Wilson; David D Eisenstat; Lucie Lafay-Cousin; Juliette Hukin; Cynthia Hawkins; Ute Bartels; Eric Bouffet
Journal:  J Neurooncol       Date:  2020-07-07       Impact factor: 4.130

Review 2.  Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.

Authors:  Pedro R Lowenstein; Maria G Castro
Journal:  Clin Immunol       Date:  2017-07-15       Impact factor: 3.969

3.  Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.

Authors:  Sophie E M Veldhuijzen van Zanten; Charlotte L L I van Meerwijk; Marc H A Jansen; Jos W R Twisk; Anna-Karenia Anderson; Lucy Coombes; Maggie Breen; Olivia J Hargrave; June Hemsley; Finella Craig; Ofelia Cruz; Gertjan J L Kaspers; Dannis G van Vuurden; Darren R Hargrave
Journal:  Neuro Oncol       Date:  2015-10-11       Impact factor: 12.300

4.  Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.

Authors:  Cassie Kline; S John Liu; Sai Duriseti; Anuradha Banerjee; Theodore Nicolaides; Shannon Raber; Nalin Gupta; Daphne Haas-Kogan; Steve Braunstein; Sabine Mueller
Journal:  J Neurooncol       Date:  2018-09-11       Impact factor: 4.130

5.  Retrospective study of diffuse intrinsic pontine glioma in the Belgian population: a 25 year experience.

Authors:  Dries Ruttens; Julie Messiaen; Alina Ferster; Caroline Piette; Stefan Schifflers; An Van Damme; Jutte van der Werff Ten Bosch; Joris Verlooy; Leen Willems; Sandra Jacobs
Journal:  J Neurooncol       Date:  2021-05-03       Impact factor: 4.130

6.  Transition readiness among adolescents with rare endocrine conditions.

Authors:  Lisette van Alewijk; Kirsten Davidse; Karlijn Pellikaan; Judith van Eck; Anita C S Hokken-Koelega; Theo C J Sas; Sabine Hannema; Aart J van der Lely; Laura C G de Graaff
Journal:  Endocr Connect       Date:  2021-04-22       Impact factor: 3.335

Review 7.  Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma.

Authors:  Pawel Buczkowicz; Cynthia Hawkins
Journal:  Front Oncol       Date:  2015-06-30       Impact factor: 6.244

8.  A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma.

Authors:  Sophie E M Veldhuijzen van Zanten; Fatma E El-Khouly; Marc H A Jansen; Dewi P Bakker; Esther Sanchez Aliaga; Cornelis J A Haasbeek; Nicole I Wolf; C Michel Zwaan; W Peter Vandertop; Dannis G van Vuurden; Gertjan J L Kaspers
Journal:  J Neurooncol       Date:  2017-07-26       Impact factor: 4.130

9.  Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.

Authors:  Lindsey M Hoffman; Sophie E M Veldhuijzen van Zanten; Niclas Colditz; Joshua Baugh; Brooklyn Chaney; Marion Hoffmann; Adam Lane; Christine Fuller; Lili Miles; Cynthia Hawkins; Ute Bartels; Eric Bouffet; Stewart Goldman; Sarah Leary; Nicholas K Foreman; Roger Packer; Katherine E Warren; Alberto Broniscer; Mark W Kieran; Jane Minturn; Melanie Comito; Emmett Broxson; Chie-Schin Shih; Soumen Khatua; Murali Chintagumpala; Anne Sophie Carret; Nancy Yanez Escorza; Timothy Hassall; David S Ziegler; Nicholas Gottardo; Hetal Dholaria; Renee Doughman; Martin Benesch; Rachid Drissi; Javad Nazarian; Nada Jabado; Nathalie Boddaert; Pascale Varlet; Géraldine Giraud; David Castel; Stephanie Puget; Chris Jones; Esther Hulleman; Piergiorgio Modena; Marzia Giagnacovo; Manila Antonelli; Torsten Pietsch; Gerrit H Gielen; David T W Jones; Dominik Sturm; Stefan M Pfister; Nicolas U Gerber; Michael A Grotzer; Elke Pfaff; André O von Bueren; Darren Hargrave; Guirish A Solanki; Filip Jadrijevic Cvrlje; Gertjan J L Kaspers; William P Vandertop; Jacques Grill; Simon Bailey; Veronica Biassoni; Maura Massimino; Raphaël Calmon; Esther Sanchez; Brigitte Bison; Monika Warmuth-Metz; James Leach; Blaise Jones; Dannis G van Vuurden; Christof M Kramm; Maryam Fouladi
Journal:  J Clin Oncol       Date:  2018-05-10       Impact factor: 44.544

10.  A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma.

Authors:  Fatma E El-Khouly; Sophie E M Veldhuijzen van Zanten; Dannis G van Vuurden; Gertjan J L Kaspers; Marc H A Jansen; Dewi P Bakker; Esther Sanchez Aliaga; N Harry Hendrikse; W Peter Vandertop
Journal:  J Neurooncol       Date:  2021-05-07       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.